Status:
TERMINATED
Chemoradiation-Induced Nausea and Emesis: Quality of Life
Lead Sponsor:
M.D. Anderson Cancer Center
Collaborating Sponsors:
Merck Sharp & Dohme LLC
Conditions:
Gastric Cancer
Pancreatic Cancer
Eligibility:
All Genders
18+ years
Brief Summary
The primary objectives of this study are: 1. To assess the preferences of cancer patients scheduled to receive chemoradiation and caregiver controls for side-effects of chemoradiation. 1. To comp...
Detailed Description
You will be interviewed about your perceptions of side effects that are related to your chemoradiation treatment. The interview will take about 20 minutes. You will be interviewed at the beginning of ...
Eligibility Criteria
Inclusion
- Patients receiving 5 to 6-week course of chemoradiation for abdominal-pelvic tumors (gastric cancers, gastro-esophageal (GE) junction, pancreatic, cervix, vulvar, endometrial, or anal) using conventional fractionation \[(180cGy-200cGy per day)\]
- Patients receiving concurrent abdominal-pelvic radiation and single agent or combination of cisplatin, paclitaxel, CPT-11, oxaliplatin or 5-FU, capecitabine, gemcitabine, or bevacizumab (Avastin).
- Patients must be least 18 years of age
- Controls must be individuals with no prior cancer diagnosis
- Controls must be at least 18 years of age
- Controls must be the caregivers of patients on this study
Exclusion
- Patients who do not have a diagnosis of cervix, endometrial, vulvar or anal cancer
- Patients who are not scheduled to receive chemoradiation treatment
- Patients who are not at least 18 years of age
- Controls - individuals who have a prior diagnosis of cancer (with the exception of non-melanoma skin cancer)
- Controls - individuals who are not at least 18 years of age
Key Trial Info
Start Date :
April 7 2004
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 8 2019
Estimated Enrollment :
207 Patients enrolled
Trial Details
Trial ID
NCT00394602
Start Date
April 7 2004
End Date
May 8 2019
Last Update
January 2 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Texas MD Anderson Cancer Center
Houston, Texas, United States, 77030